Cargando…
Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures
[Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397397/ https://www.ncbi.nlm.nih.gov/pubmed/34292730 http://dx.doi.org/10.1021/acs.langmuir.1c01340 |
_version_ | 1783744605677682688 |
---|---|
author | Castelletto, Valeria Seitsonen, Jani Ruokolainen, Janne Barnett, Sarah A. Sandu, Callum Hamley, Ian W. |
author_facet | Castelletto, Valeria Seitsonen, Jani Ruokolainen, Janne Barnett, Sarah A. Sandu, Callum Hamley, Ian W. |
author_sort | Castelletto, Valeria |
collection | PubMed |
description | [Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements provide similar values for the CAC, and there is also evidence from circular dichroism spectroscopy for a possible conformational change in the peptides at the same concentration. Cryogenic transmission electron microscopy indicates the formation of micelle-like aggregates above the CAC, which can thus be considered a critical micelle concentration, and the formation of aggregates with a hydrodynamic radius of ∼6–7 nm is also evidenced by dynamic light scattering. We also used synchrotron radiation X-ray diffraction to determine the single-crystal structure of captopril and lisinopril. Our results improve the accuracy of previous data reported in the literature, obtained using conventional X-ray sources. We also studied the structure of aqueous solutions containing captopril or lisinopril at high concentrations. The aggregation may be driven by intermolecular interactions between the proline moiety of captopril molecules or between the phenylalanine moiety of lisinopril molecules. |
format | Online Article Text |
id | pubmed-8397397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-83973972021-08-31 Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures Castelletto, Valeria Seitsonen, Jani Ruokolainen, Janne Barnett, Sarah A. Sandu, Callum Hamley, Ian W. Langmuir [Image: see text] The peptide angiotensin-converting enzyme inhibitors captopril and lisinopril are unexpectedly shown to exhibit critical aggregation concentration (CAC) behavior through measurements of surface tension, electrical conductivity, and dye probe fluorescence. These three measurements provide similar values for the CAC, and there is also evidence from circular dichroism spectroscopy for a possible conformational change in the peptides at the same concentration. Cryogenic transmission electron microscopy indicates the formation of micelle-like aggregates above the CAC, which can thus be considered a critical micelle concentration, and the formation of aggregates with a hydrodynamic radius of ∼6–7 nm is also evidenced by dynamic light scattering. We also used synchrotron radiation X-ray diffraction to determine the single-crystal structure of captopril and lisinopril. Our results improve the accuracy of previous data reported in the literature, obtained using conventional X-ray sources. We also studied the structure of aqueous solutions containing captopril or lisinopril at high concentrations. The aggregation may be driven by intermolecular interactions between the proline moiety of captopril molecules or between the phenylalanine moiety of lisinopril molecules. American Chemical Society 2021-07-22 2021-08-03 /pmc/articles/PMC8397397/ /pubmed/34292730 http://dx.doi.org/10.1021/acs.langmuir.1c01340 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Castelletto, Valeria Seitsonen, Jani Ruokolainen, Janne Barnett, Sarah A. Sandu, Callum Hamley, Ian W. Self-Assembly of Angiotensin-Converting Enzyme Inhibitors Captopril and Lisinopril and Their Crystal Structures |
title | Self-Assembly of Angiotensin-Converting Enzyme Inhibitors
Captopril and Lisinopril and Their Crystal Structures |
title_full | Self-Assembly of Angiotensin-Converting Enzyme Inhibitors
Captopril and Lisinopril and Their Crystal Structures |
title_fullStr | Self-Assembly of Angiotensin-Converting Enzyme Inhibitors
Captopril and Lisinopril and Their Crystal Structures |
title_full_unstemmed | Self-Assembly of Angiotensin-Converting Enzyme Inhibitors
Captopril and Lisinopril and Their Crystal Structures |
title_short | Self-Assembly of Angiotensin-Converting Enzyme Inhibitors
Captopril and Lisinopril and Their Crystal Structures |
title_sort | self-assembly of angiotensin-converting enzyme inhibitors
captopril and lisinopril and their crystal structures |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397397/ https://www.ncbi.nlm.nih.gov/pubmed/34292730 http://dx.doi.org/10.1021/acs.langmuir.1c01340 |
work_keys_str_mv | AT castellettovaleria selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures AT seitsonenjani selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures AT ruokolainenjanne selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures AT barnettsaraha selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures AT sanducallum selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures AT hamleyianw selfassemblyofangiotensinconvertingenzymeinhibitorscaptoprilandlisinoprilandtheircrystalstructures |